Drew M. Pardoll
Affiliations: | Johns Hopkins University, Baltimore, MD |
Area:
Molecular Biology, Immunology, Cell BiologyGoogle:
"Drew Pardoll"Parents
Sign in to add mentor| William Erwin Paul | post-doc | National Institute of Health | |
| Bert Vogelstein | post-doc | Johns Hopkins Medical School (Chemistry Tree) |
Children
Sign in to add trainee| Kevin S. Gorski | grad student | 2001 | Johns Hopkins |
| Ching-Tai Huang | grad student | 2001 | Johns Hopkins |
| Su-Yi Tseng | grad student | 2001 | Johns Hopkins |
| Anne M. Beckerleg | grad student | 2002 | Johns Hopkins |
| Sara I. Pai | grad student | 2002 | Johns Hopkins |
| Loise M. Francisco | grad student | 2004 | Johns Hopkins |
| Ken-Yu Lin | grad student | 2006 | Johns Hopkins |
| Caryn D. Tong | grad student | 2006 | Johns Hopkins |
| Monica V. Goldberg | grad student | 2007 | Johns Hopkins |
| Timothy J. Harris | grad student | 2009 | Johns Hopkins |
| Maria A. Pletneva | grad student | 2009 | Johns Hopkins |
| Huang-Yu A. Yang | grad student | 2013 | Johns Hopkins |
| Hyam Levitsky | post-doc | Johns Hopkins Medical School (E-Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pulliam T, Jani S, Jing L, et al. (2024) Circulating cancer-specific CD8 T cell frequency is associated with response to PD-1 blockade in Merkel cell carcinoma. Cell Reports. Medicine. 101412 |
| Zheng Y, Lebid A, Chung L, et al. (2024) Targeting the activin receptor 1C on CD4+ T cells for cancer immunotherapy. Oncoimmunology. 13: 2297503 |
| Bergerud KMB, Berkseth M, Pardoll DM, et al. (2023) Radiation Therapy and Myeloid-derived Suppressor Cells: Breaking Down Their Cancerous Partnership. International Journal of Radiation Oncology, Biology, Physics |
| Dykema AG, Zhang J, Cheung LS, et al. (2023) Lung tumor-infiltrating T have divergent transcriptional profiles and function linked to checkpoint blockade response. Science Immunology. 8: eadg1487 |
| Wright KM, DiNapoli SR, Miller MS, et al. (2023) Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen. Nature Communications. 14: 5063 |
| Schad SE, Chow A, Mangarin L, et al. (2022) Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions. The Journal of Experimental Medicine. 219 |
| Dykema AG, Zhang B, Woldemeskel BA, et al. (2022) SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection. Ebiomedicine. 80: 104048 |
| Pearlman AH, Hwang MS, Konig MF, et al. (2022) Author Correction: Targeting public neoantigens for cancer immunotherapy. Nature Cancer. 2: 865-867 |
| Pearlman AH, Hwang MS, Konig MF, et al. (2021) Targeting public neoantigens for cancer immunotherapy. Nature Cancer. 2: 487-497 |
| Caushi JX, Zhang J, Ji Z, et al. (2021) Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers. Nature |